-
AdvanSource taps PLC Medical CEO Tauscher for board of directors
AdvanSource Biomaterials Corp. (NYSE:ASB), a leading developer, manufacturer and seller of advanced polymer technologies and materials for a broad range of medical devices, today announced that Mr. Mark Tauscher has been appointed to the Company’s Board of Directors, effective October 5, 2010. Mr. Tauscher is the President, Chief Executive Officer and a director of PLC Medical Systems, Inc. and PLC Systems, Inc., where he has served in such capacity since January 2000.
Read more -
IDEXX Laboratories Names Giovani Twigge Corporate Vice President, Human Resources
IDEXX Laboratories Inc. (NSDQ:IDXX), today announced the appointment of Giovani Twigge as Corporate Vice President, Human Resources. In this capacity, Twigge will oversee worldwide human resources and business and employee communications functions.
Read more -
Obagi Medical Products Announces Changes to its Senior Management
Obagi Medical Products, Inc. announced today that President and Chief Executive Officer Steven R. Carlson has resigned, effective immediately, from those posts and from the Company’s Board of Directors. The Company also announced that Mr. Albert F. Hummel, a Director, has been appointed as interim President and Chief Executive Officer. Mr. Hummel has been a Director of Obagi since 2005.
Read more -
Thomas Morizio Named President and Chief Operating Officer of ACIST Medical Systems, Inc.
Bracco announces that it has appointed Thomas Morizio as the new President and Chief Operating Officer of ACIST Medical Systems, Inc., a leading provider of contrast delivery systems for cardiology and radiology imaging and part of the Bracco Group. Morizio, formerly Vice President of Marketing for the Kyphon Division at Medtronic, began last week leading the global efforts of the Minnesota based company.
Read more -
Aperio adds Healthcare Veteran Steven Russell as VP of Corporate Development
Aperio, the global leader in digital pathology for the healthcare and life sciences industries, has appointed Steven V. Russell to the newly created position of vice president of corporate development.
Read more -
Intrexon Appoints Former NIH Investigator to Identify High Value Therapeutic Opportunities
Intrexon Corporation, a privately held synthetic biology company, today announced the appointment of William E. Fogler, Ph.D., as Senior Director of Portfolio Analysis and Planning for its Human Therapeutics Division. Dr. Fogler’s efforts will focus on identifying high value therapeutic opportunities for which Intrexon’s proprietary technologies and capabilities confer an unparalleled advantage.
Read more -
Renowned Colonoscopy Inventor Appointed to EDP Biotech Scientific Advisory Board
EDP Biotech, a Knoxville-based medical device company, announced the appointment of world-renowned physician Dr. Bergein Overholt to the company’s Scientific Advisory Board. Dr. Overholt, one of the nation’s leading gastroenterologists, is known world-wide as the inventor of the colonoscopy, a revolutionary development in medical care and early cancer detection.
Read more -
BioClinica Appoints James W. Lovett to Its Board of Directors
BioClinica Inc. (NSDQ:BIOC), a leading provider of clinical trial management services, today announced that it has appointed James W. Lovett to its Board of Directors, increasing the size of the Board to nine members.
Read more -
Biocept Inc. Announces New Director Appointment
Biocept Inc., an emerging leader in biotechnology, announced today the appointment of Bruce E. Gerhardt as Director.
Read more -
TDC Medical names Mike Sullivan as GM of East Coast ops
TDC Medical is pleased to announce the recent addition of Mike Sullivan as General Manager of
its east cost operations, headquartered in Marlborough, MA.
Read more (PDF)